Geron Corp logo

Geron Corp

NAS:GERN (USA)   Ordinary Shares
$ 2.26 +0.26 (+13%) 11:09 PM EST
At Loss
P/B:
4.95
Enterprise V:
$ 979.52M
Volume:
12.50M
Avg Vol (2M):
7.01M
Also Trade In:
Volume:
12.50M
At Loss
Avg Vol (2M):
7.01M

Business Description

Geron Corp logo
Geron Corp
NAICS : 325412 SIC : 2834
ISIN : US3741631036

Share Class Description:

GERN: Ordinary Shares
Description
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses global rights to this drug. the company operates as a single segment, the development of therapeutic products for oncology.
Name Current Vs Industry Vs History
Cash-To-Debt 5.98
Equity-to-Asset 0.63
Debt-to-Equity 0.23
Debt-to-EBITDA -0.32
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.16
Distress
Grey
Safe
Beneish M-Score 0.25
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 74.59
9-Day RSI 65.23
14-Day RSI 60.18
6-1 Month Momentum % -22.58
12-1 Month Momentum % -30.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.16
Quick Ratio 3.16
Cash Ratio 3.1

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25
Shareholder Yield % -17.43

Financials (Next Earnings Date:2024-05-10 Est.)

GERN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GERN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Geron Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.237
EPS (TTM) ($) -0.33
Beta 0.44
Volatility % 56.69
14-Day RSI 60.18
14-Day ATR ($) 0.160677
20-Day SMA ($) 2.01275
12-1 Month Momentum % -30.94
52-Week Range ($) 1.68 - 3.735
Shares Outstanding (Mil) 543.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Geron Corp Filings

Filing Date Document Date Form
No Filing Data

Geron Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Geron Corp Frequently Asked Questions

What is Geron Corp(GERN)'s stock price today?
The current price of GERN is $2.26. The 52 week high of GERN is $3.74 and 52 week low is $1.68.
When is next earnings date of Geron Corp(GERN)?
The next earnings date of Geron Corp(GERN) is 2024-05-10 Est..
Does Geron Corp(GERN) pay dividends? If so, how much?
Geron Corp(GERN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1